RezaShiraziMDFACRO,MS, EE

PubMed

• 47 citations
  Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
  Donald B. Fuller, James C. Wurzer, Reza Shirazi, Stephen S. Bridge, Jonathan Law
  International Journal of Radiation Oncology, Biology, Physics. 2020-02-01
• 42 citations
  High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, dis...
  Donald B. Fuller, James Wurzer, Reza Shirazi, Stephen S. Bridge, Jonathan Law
  Practical Radiation Oncology. 2015-11-01
• 4 citations
  Prostate SBRT: Comparison the Efficacy and Toxicity of Two Different Dose Fractionation Schedules.
  Donald B. Fuller, John Naitoh, Reza Shirazi, Tami Crabtree, George Mardirossian
  Frontiers in Oncology. 2020-06-25

Journal Articles

• High-dose-rate stereotactic body radiation therapy for post radiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, di...  
  Fuller DB, Wurzer J, Shirazi R, Bridge SS, Law J, Mardirossian G, Pract Radiation Oncology, 1/1/2015
• A Phase III Randomized Trial to Assess the Efficacy on Intraoperative Steroid Use in Decreasing Acute Urinary Retention Following Transperineal Radioactive Seed Implan...  
  Mierzwa ML, Barrett WL, Redmond KP, Shirazi R, Kastl A, International Journal of Radiation Oncology, Biology, Physics, 1/1/2007
• Incidence and Clinical Course of Hemorrhagic Radiation Proctitis after Iodine-125 Prostate Brachytherapy  
  Mishra MV, Shirazi R, Barrett WL, Clinics in Genitourinary Cancer, 1/1/2007

Abstracts/Posters

• Virtual HDR SBRT for Localized Prostatic Carcinoma: Efficacy and Quality of Life Assessment.
  Fuller DB, Shirazi R, Naitoh J, Mardirossian G, ASTRO 53rd Annual Meeting, Miami Beach, Florida, 10/1/2011
• CyberKnife Stereotactic Body Radiation Therapy for Palliation and Local Control in Patients with Advanced Pancreatic Cancer: A Retrospective Review.
  Shirazi R, Goldfarb PM, Fuller DB, Sanati H, Journal of Clinical Oncology 29: 2011 (suppl; abstract e14506), Chicago, IL, 6/1/2011
• CyberKnife Stereotactic Body Radiation Therapy for Palliation and Local Control in Patients with Advanced Pancreatic Cancer: A Retrospective Review.
  Shirazi R, Goldfarb PM, Fuller DB, Sanati H, Journal of Clinical Oncology, 1/1/2011
• Virtual HDR SBRT for Localized Prostatic Carcinoma: Efficacy and Quality of Life Assessment.
  Fuller DB, Shirazi R, Naitoh J, Mardirossian G, American Society for Radiation Oncology 53rd Annual Meeting, Miami Beach, FL, 1/1/2011
• Hypofractionated CyberKnife Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer.
  Shirazi R, Goldfarb P, Fuller D, Smith, D, Tova Y, Mansy G, Giap H, Sanati H, 2011 CyberKnife Robotic Radiosurgery Summit, San Francisco, CA, 1/1/2011
• CyberKnife Treatment for Posterior Lung Tumor: Supine versus Prone Position?
  Giap HB, Fuller DB, Mardirossian G, Muniruzzaman MM, Smith DE, Shirazi R, Mansy GJ, Tova Y, Ijaz T, Lin R, 9th Annual CyberKnife Scientific Meeting, Dallas, TX, 1/1/2010
• Partial Breast Irradiation with CyberKnife: Solutions to Overcome the Technical Issues to the First Patient Treatment.
  Giap HB, Fuller DB, Mardirossian G, Muniruzzaman MM, Smith DE, Mansy GJ, Tova Y, Shirazi R, Ijaz T, Lin R, 9th Annual CyberKnife Scientific Meeting, Dallas, TX, 1/1/2010
• Assessing the impact of alternative definitions of biochemical failure in prostate cancer patients treated with brachytherapy alone.
  R. Shirazi, R. C. Buncher, Y. Gao, W. L. Barrett, Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings, 1/1/2006
• Incidence and clinical course of hemorrhagic radiation proctitis following 125I prostate Brachytherapy.
  M. V. Mishra, R. Shirazi, W. Barrett, Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings, 1/1/2006
• HDR for recurrent/persistent Head and Neck Cancer, Long Beach Memorial experience.
  R. Shirazi, A. Puthawala, A. Shrama, N. Syed, 2006 ACRO Annual Meeting, FL, 1/1/2006
• What PSA nadir after prostate brachytherapy is associated with biochemical disease control?
  M. V. Mishra, R. Shirazi, K. Hertzfeld, W. Barrett, Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings, 1/1/2005
• Age as a prognostic factor for prostate cancer patients treated with brachytherapy.
  A. Nagavi, R. Shirazi, N. Dunlap, W. Barrett, Journal of Clinical Oncology ,2005 ASCO Annual Meeting Proceedings, 1/1/2005
• Efficacy of brachytherapy for prostate cancer in organ transplant patients.
  K. E. Hertzfeld, R. Shirazi, W. Barrett, Journal of Clinical Oncology ,2005 ASCO Annual Meeting Proceedings, 1/1/2005
• Neoadjuvant hormonal therapy plus brachytherapy vs. brachytherapy alone for patients with prostate cancer: A single institution retrospective study.
  R. Shirazi, M. Mishra, A. Kleimeyer, W. Kassing, W. Barrett, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings, 1/1/2004
• The prognostic importance of Biopsy proven unilateral vs. bilateral disease in patients treated with I-125 seed implant for localized prostate cancer : A single instit...
  N. Dunlap, R. Shirazi, A. Naghavi, W. Barrett, ASCO Annual Meeting Proceedings, 1/1/2004
• Second messenger stimulation of Na/Mg exchange in skeletal muscle.
  R. Shirazi, E. Dessner, E. Kim, C. Pena-Rasgado & H. Rasgado-Flores, FASEB J, 1/1/1999
• Modulation of extracellular Mg-dependent Na efflux in skeletal muscle.
  R. Shirazi, R. Modak, J. Tie, P. Yee, J. DeSantiago, C. Pena-Rasgado, H. Gonzalez-Serratos and H. Rasgado-Flores, FASEB J, 1/1/1998
• Join now to see all